Bird Flu (H5N1 Avian Influenza) Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition: InfluenzaIntervention: Biological: VAX161-01C vaccineSponsors: VaxInnate Corporation; VaxInnate CorporationActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials

Immune Responses to H5N1 Vaccine With and Without MF59 Adjuvant
Conditions: Influenza; HealthyInterventions: Biological: H5N1 vaccine plus MF59 adjuvant; Biological: H5N1 vaccine without adjuvantSponsors: National Heart, Lung, and Blood Institute (NHLBI); Center for Human Immunology, Autoimmunity and Inflammation; National Institutes of Health Clinical Center (CC)Completed - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2012 Category: Research Source Type: clinical trials

H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition: InfluenzaInterventions: Biological: H5N1 Vaccine; Drug: ASO3 AdjuvantSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified October 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials

H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition: InfluenzaInterventions: Drug: ASO3 Adjuvant; Biological: H5N1 VaccineSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials

H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition: InfluenzaInterventions: Biological: H5N1 Vaccine; Drug: ASO3 AdjuvantSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials